NEW YORK (GenomeWeb News) – Insight Genetics today announced an exclusive, worldwide licensing deal with St. Jude Children's Research Hospital for a genetic test to improve donor matching in bone marrow transplants.

Under the terms of the deal, Insight will license from St. Jude's the KIR/KIR-Ligand Assay, which Insight said has been shown to prevent the recurrence of cancer in transplant recipients and to reduce the risk of death following bone marrow transplantation by about 60 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.